Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Covington
Julphar
US Department of Justice
AstraZeneca
Express Scripts
Chubb
Argus Health
Boehringer Ingelheim

Generated: December 16, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR BELVIQ

« Back to Dashboard

Clinical Trials for Belviq

Trial ID Title Status Sponsor Phase Summary
NCT01880502 Pharmacokinetic Study of Belviq in Adult Korean Volunteers Completed IlDong Pharmaceutical Co Ltd Phase 1 A randomized, double-blind, placebo-controlled, single-dose, dose escalation study (Phase I) to evaluate the tolerability and pharmacokinetics of Belviq in adult Korean volunteers.
NCT01962402 Lorcaserin for Weight Loss Management in Patients on Antipsychotics: A Pilot Study Unknown status Southern California Institute for Research and Education Phase 4 The purpose of this study is to determine whether lorcaserin is effective for weight reduction in patients with weight gain as a result of antipsychotic medications.
NCT02019264 A Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Mult Active, not recruiting Thrombolysis In Myocardial Infarction (TIMI) Academic Research Organization Phase 4 This is a multicenter, randomized, double-blind, placebo-controlled, parallel-group study in overweight and obese subjects with CV disease and/or multiple CV risk factors.
NCT02019264 A Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Mult Active, not recruiting Eisai Inc. Phase 4 This is a multicenter, randomized, double-blind, placebo-controlled, parallel-group study in overweight and obese subjects with CV disease and/or multiple CV risk factors.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Belviq

Condition Name

Condition Name for Belviq
Intervention Trials
Obesity 5
Overweight 3
Opioid-Related Disorders 2
Smoking Cessation 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Belviq
Intervention Trials
Disease 7
Weight Loss 5
Overweight 5
Weight Gain 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Belviq

Trials by Country

Trials by Country for Belviq
Location Trials
United States 85
Australia 6
New Zealand 6
Canada 5
Mexico 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Belviq
Location Trials
New York 6
North Carolina 5
Virginia 5
Minnesota 4
Florida 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Belviq

Clinical Trial Phase

Clinical Trial Phase for Belviq
Clinical Trial Phase Trials
Phase 4 6
Phase 3 1
Phase 2/Phase 3 1
[disabled in preview] 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Belviq
Clinical Trial Phase Trials
Recruiting 9
Not yet recruiting 6
Completed 5
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Belviq

Sponsor Name

Sponsor Name for Belviq
Sponsor Trials
National Institute on Drug Abuse (NIDA) 7
Virginia Commonwealth University 3
New York State Psychiatric Institute 3
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Belviq
Sponsor Trials
Other 20
NIH 10
Industry 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Covington
Cantor Fitzgerald
AstraZeneca
Mallinckrodt
Dow
Cerilliant
Fish and Richardson
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.